Skip to content
Search

Latest Stories

NHSE pledges to eliminate cervical cancer by 2040

England is among the first countries in the world to set this elimination ambition

The National Health Service England (NHSE) aims to eliminate cervical cancer by 2040 by making the lifesaving Human Papillomavirus (HPV) vaccination easily accessible to people and increasing cervical screening uptake.


In addition to the campaign, the NHS is expanding the outreach of cervical screening more than ever before.

Last year, the health service invited over five million people aged 25 to 64 for the screening, out of which 3.5 million were tested.

Moreover, self-sampling will be trialled to see if the service can introduced as part of national screening.

England is among the first countries in the world to set this elimination ambition, which could save thousands of lives every year in the country.

Amanda Pritchard, chief executive of Officer of NHS England, announced the health service’s new goal and how to achieve it at the NHS Providers’ annual conference today (15 November).

Pritchard said: “It is truly momentous to be able to set out such an important, life-saving ambition today – to eliminate cervical cancer would be an incredible achievement and through a combination of our HPV vaccination programme, and our highly effective cervical screening programme, it could become a reality in the next two decades.

“Vaccination and screening are the key tools which mean we are one step closer to achieving this and the NHS is already making it easier than ever before for people to protect themselves and their families – whether it’s through community outreach in areas of lower uptake or expanding the NHS app so that everyone has their vaccine history and booking options in the palm of their hand.

“As ever, the public can play their part by coming forward for their vaccines and screening appointments when invited – to achieve our goal of eliminating cervical cancer, we need as many people as possible to take up the offer, so please don’t delay – it could save your life,” she added.

The NHS would be strengthening efforts to eliminate the HPV virus, which causes up to 99% of cervical cancers.

Health and care professionals will be supported to identify those who most need the HPV vaccine, through targeted outreach and offering jabs in more convenient settings, the NHSE said.

Further, new measures will be introduced to give local health teams more flexibility to locate vaccine services in convenient local places such as libraries, community centres and local leisure or sports facilities.

Alongside routine vaccinations, NHS staff will offer blood pressure tests and other health checks and advice.

Steve Russell, chief delivery officer and national director for vaccinations and screening for NHS England, said: “Vaccination and screening are some of the most powerful tools we have for preventing disease and for keeping people from becoming unwell.”

Get HPV vaccine and cervical screening

The HPV vaccine prevents invasive strains of the virus as well as some mouth and throat cancers.

This vaccine is given to both girls and boys in secondary school to protect them against catching the HPV infection and developing into pre-cancerous and cancer cells.

To ensure that people are up to date with their vaccinations, the NHS App is being expanded with a new dedicated space that allows people to view their full vaccine record, and options to book appointments.

NHS screening helps prevent cervical cancer by using a highly effective test to check for high-risk HPV which may cause abnormal cells to develop in the cervix.

These abnormal cells can over time turn into cancer if left untreated, the health service confirmed.

For the elimination of cervical cancer, more women should come forward for their routine cervical screening appointments.

Currently, a third of women invited do not take up the offer, the NHS has revealed.

In England, around 2,700 women are diagnosed with cervical cancer each year, but the NHS screening programme helps save around 5,000 lives each year.

As per the World Health Organisation (WHO), cervical cancer is considered eliminated as a public health problem when the incidence rate is lower than four per 100,000 women.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less